Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | DHODH | Q02127 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL9307473 | 1.00 | PLA2G4B (0.46) | PLA2G4BSMN1; SMN2DHODHPOLBHSD17B10 | |
| Iodide SCHEMBL9307244 | 0.96 | SMN1; SMN2 (0.47) | PLA2G4BSMN1; SMN2 | |
| Iodide SCHEMBL9309225 | 0.96 | SMN1; SMN2 (0.47) | PLA2G4BSMN1; SMN2 | |
| Iodide SCHEMBL9307320 | 0.90 | PLA2G4B (0.46) | PLA2G4BSMN1; SMN2DHODHHSD17B10CTSD | |
| Iodide SCHEMBL9308445 | 0.90 | PLA2G4B (0.46) | PLA2G4BSMN1; SMN2DHODHHSD17B10CTSD | |
| Iodide SCHEMBL9306859 | 0.90 | PLA2G4B (0.45) | PLA2G4BSMN1; SMN2DHODHHSD17B10CTSD | |
| Iodide SCHEMBL9306780 | 0.90 | PLA2G4B (0.45) | PLA2G4BSMN1; SMN2DHODHHSD17B10CTSD | |
| Iodide SCHEMBL9307178 | 0.89 | LMNA (0.44) | SMN1; SMN2 | |
| Iodide SCHEMBL9307144 | 0.89 | LMNA (0.44) | SMN1; SMN2 | |
| Iodide SCHEMBL9307722 | 0.87 | SMN1; SMN2 (0.46) | PLA2G4BSMN1; SMN2DHODHHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5328921-A | Antagonist of platelet activating factor | AMERICAN CYANAMID COMPANY (US) | 1994-07-12 | — | — | US | disclosed |